These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 7511190)
1. Use of cell surface antigen phenotype in guiding therapeutic decisions in chronic myelomonocytic leukemia. Woodlock TJ; Seshi B; Sham RL; Cyran EM; Bennett JM Leuk Res; 1994 Mar; 18(3):173-81. PubMed ID: 7511190 [TBL] [Abstract][Full Text] [Related]
2. Acute myeloid leukemia with t(6;9) (p23;q34): association with myelodysplasia, basophilia, and initial CD34 negative immunophenotype. Alsabeh R; Brynes RK; Slovak ML; Arber DA Am J Clin Pathol; 1997 Apr; 107(4):430-7. PubMed ID: 9124211 [TBL] [Abstract][Full Text] [Related]
3. Detection of molecular targets on the surface of CD34+CD38- bone marrow cells in myelodysplastic syndromes. Xie W; Wang X; Du W; Liu W; Qin X; Huang S Cytometry A; 2010 Sep; 77(9):840-8. PubMed ID: 20662087 [TBL] [Abstract][Full Text] [Related]
4. Negative effect of DNA hypermethylation on the outcome of intensive chemotherapy in older patients with high-risk myelodysplastic syndromes and acute myeloid leukemia following myelodysplastic syndrome. Grövdal M; Khan R; Aggerholm A; Antunovic P; Astermark J; Bernell P; Engström LM; Kjeldsen L; Linder O; Nilsson L; Olsson A; Wallvik J; Tangen JM; Oberg G; Jacobsen SE; Hokland P; Porwit A; Hellström-Lindberg E Clin Cancer Res; 2007 Dec; 13(23):7107-12. PubMed ID: 18056190 [TBL] [Abstract][Full Text] [Related]
5. [Study on the immunophenotypes of bone marrow cells from patients with myelodysplastic syndromes and its clinical implications]. Wang JY; Li XM; Li FJ; Chen XG Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2002 Apr; 10(2):173-4. PubMed ID: 12513825 [TBL] [Abstract][Full Text] [Related]
7. Differences in CD33 intensity between various myeloid neoplasms. Jilani I; Estey E; Huh Y; Joe Y; Manshouri T; Yared M; Giles F; Kantarjian H; Cortes J; Thomas D; Keating M; Freireich E; Albitar M Am J Clin Pathol; 2002 Oct; 118(4):560-6. PubMed ID: 12375643 [TBL] [Abstract][Full Text] [Related]
8. Dismal outcome of acute myeloid leukemia secondary to myelodysplastic syndrome and chronic myelomonocytic leukemia after azacitidine failure in a daily-life setting. Niscola P; Tendas A; Cupelli L; Giovannini M; Piccioni D; Scaramucci L; Dentamaro T; Del Poeta G; de Fabritiis P Acta Haematol; 2015; 133(1):64-6. PubMed ID: 25139255 [No Abstract] [Full Text] [Related]
9. Detection of minimal residual disease in a patient having acute myelogenous leukemia with t(16;21)(p11;q22) treated by allogeneic bone marrow transplantation. Okoshi Y; Shimizu S; Kojima H; Obara N; Mukai HY; Komeno T; Hasegawa Y; Mori N; Nagasawa T Acta Haematol; 2001; 105(1):45-8. PubMed ID: 11340253 [TBL] [Abstract][Full Text] [Related]
10. Surface marker expression in acute myeloid leukaemia at first relapse. Thomas X; Campos L; Archimbaud E; Shi ZH; Treille-Ritouet D; Anglaret B; Fiere D Br J Haematol; 1992 May; 81(1):40-4. PubMed ID: 1381608 [TBL] [Abstract][Full Text] [Related]
11. Absence of prognostic impact of CD13 and/or CD33 antigen expression in adult acute lymphoblastic leukemia. Results of the GIMEMA ALL 0496 trial. Vitale A; Guarini A; Ariola C; Meloni G; Perbellini O; Pizzuti M; De Gregoris C; Mettivier V; Pastorini A; Pizzolo G; Vignetti M; Mandelli F; Foà R Haematologica; 2007 Mar; 92(3):342-8. PubMed ID: 17339183 [TBL] [Abstract][Full Text] [Related]
12. The proliferative activity of myelopoiesis in myelodysplasia evaluated by multiparameter flow cytometry. Jensen IM; Hokland P Br J Haematol; 1994 Jul; 87(3):477-82. PubMed ID: 7993787 [TBL] [Abstract][Full Text] [Related]
13. Flow cytometric detection of residual disease in acute leukemia by assaying blasts co-expressing myeloid and lymphatic antigens. Syrjälä M; Anttila VJ; Ruutu T; Jansson SE Leukemia; 1994 Sep; 8(9):1564-70. PubMed ID: 7522295 [TBL] [Abstract][Full Text] [Related]
14. [Immunologic characteristics and prognosis of acute myeloid leukemia M1]. Zhao F; Chen Y Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Aug; 15(4):687-91. PubMed ID: 17708783 [TBL] [Abstract][Full Text] [Related]
15. Phenotypic and functional analysis of bone marrow progenitor cell compartment in bone marrow failure. Maciejewski JP; Anderson S; Katevas P; Young NS Br J Haematol; 1994 Jun; 87(2):227-34. PubMed ID: 7524621 [TBL] [Abstract][Full Text] [Related]
16. Acute lymphoblastic leukemia following preleukemic syndromes in adults. Escudier SM; Albitar M; Robertson LE; Andreeff M; Pierce S; Kantarjian HM Leukemia; 1996 Mar; 10(3):473-7. PubMed ID: 8642864 [TBL] [Abstract][Full Text] [Related]
17. [Leukemia cutis arising at the site of injection of a tetanus vaccine booster]. Guinovart RM; Carrascosa JM; Ferrándiz C Actas Dermosifiliogr; 2010 Oct; 101(8):727-9. PubMed ID: 20965018 [No Abstract] [Full Text] [Related]
18. Absence of aberrant myeloid progenitors by flow cytometry is associated with favorable response to azacitidine in higher risk myelodysplastic syndromes. Alhan C; Westers TM; van der Helm LH; Eeltink C; Huls G; Witte BI; Buchi F; Santini V; Ossenkoppele GJ; van de Loosdrecht AA Cytometry B Clin Cytom; 2014 May; 86(3):207-15. PubMed ID: 24474614 [TBL] [Abstract][Full Text] [Related]
19. Characteristics of the phenotypic abnormalities of bone marrow cells in childhood myelodysplastic syndromes and juvenile myelomonocytic leukemia. Oliveira AF; Tansini A; Vidal DO; Lopes LF; Metze K; Lorand-Metze I Pediatr Blood Cancer; 2017 Apr; 64(4):. PubMed ID: 27748021 [TBL] [Abstract][Full Text] [Related]
20. Analysis of myeloid and lymphoid markers on the surface and in the cytoplasm of mononuclear bone marrow cells in patients with myelodysplastic syndrome. Schlesinger M; Silverman LR; Jiang JD; Yagi MJ; Holland JF; Bekesi JG J Clin Lab Immunol; 1996; 48(4):149-66. PubMed ID: 9819667 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]